306 related articles for article (PubMed ID: 11356926)
1. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Ueda K; Kato Y; Komatsu K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
[TBL] [Abstract][Full Text] [Related]
2. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
[TBL] [Abstract][Full Text] [Related]
5. Species differences in the transport activity for organic anions across the bile canalicular membrane.
Ishizuka H; Konno K; Shiina T; Naganuma H; Nishimura K; Ito K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1999 Sep; 290(3):1324-30. PubMed ID: 10454510
[TBL] [Abstract][Full Text] [Related]
6. Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension.
Gewirtz DA; Plotkin JH; Randolph JK
Cancer Res; 1984 Sep; 44(9):3846-50. PubMed ID: 6744302
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
Poirier A; Funk C; Scherrmann JM; Lavé T
Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
[TBL] [Abstract][Full Text] [Related]
8. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.
Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I
Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177
[TBL] [Abstract][Full Text] [Related]
10. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats.
Hu J; Liu X; Xie L; Wang G; Liu H
Xenobiotica; 2007 Jun; 37(6):579-91. PubMed ID: 17614005
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats.
Han YH; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 1999 Oct; 291(1):204-12. PubMed ID: 10490906
[TBL] [Abstract][Full Text] [Related]
12. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
[TBL] [Abstract][Full Text] [Related]
13. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
[TBL] [Abstract][Full Text] [Related]
14. Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes.
Jones HM; Hallifax D; Houston JB
Drug Metab Dispos; 2004 May; 32(5):572-80. PubMed ID: 15100181
[TBL] [Abstract][Full Text] [Related]
15. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
16. Canalicular membrane transport is primarily responsible for the difference in hepatobiliary excretion of triethylmethylammonium and tributylmethylammonium in rats.
Han YH; Chung SJ; Shim CK
Drug Metab Dispos; 1999 Aug; 27(8):872-9. PubMed ID: 10421613
[TBL] [Abstract][Full Text] [Related]
17. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
[TBL] [Abstract][Full Text] [Related]
18. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats.
Takikawa H; Sugiyama Y; Fernandez-Checa JC; Kuhlenkamp J; Ookhtens M; Kaplowitz N
Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats.
Fuksa L; Brcakova E; Kolouchova G; Hirsova P; Hroch M; Cermanova J; Staud F; Micuda S
Toxicology; 2010 Jan; 267(1-3):165-71. PubMed ID: 19922765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
